MedTrace Logo

Continuous Glucose Monitoring and Clinical Outcomes in Diabetes on Peritoneal Dialysis

NCT07790276 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2026-08-27

No results posted yet for this study

Summary

This prospective, multicenter observational study will evaluate glucose profiles using continuous glucose monitoring (CGM) in 100 adults with diabetes receiving peritoneal dialysis (PD) or planning to start PD within 3 months. The study will examine associations between CGM metrics and PD regimen, glucose-lowering treatment, conventional glycemic markers, dialysis-related measures, and clinical outcomes including glycemic emergencies, hospitalizations, cardiovascular events, and mortality over 12 months.

Conditions

  • Continuous Glucose Monitoring
  • ESRD (End-Stage Renal Disease)
  • Peritoneal Dialysis (PD)
  • Diabetes Mellitus (DM)

Interventions

DEVICE

Continuous glucose monitoring system

Sibionics GS3 CGM

Sponsors & Collaborators

  • Elaine Chow

    lead OTHER

Principal Investigators

  • Elaine Chow · Department of Medicine and Therapeutics, The Chinese University of Hong Kong

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-31
Primary Completion
2028-06-30
Completion
2028-09-30

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07790276 on ClinicalTrials.gov